COMP <GO>
CLSK vs MS // EV/EBITDA & P/E VALUATION
CleanSpark Inc. (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CLSK 10
— MS 5
▲ EV/EBITDA & P/E VALUATION LEADER: CLSK
LAST: $7.67 (-6.46%) • MKT CAP: $2.11B
valuation
7.1x
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
valuation
31.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLSK VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLSK | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.20% | 41.00% | +14.20 | CLSK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.50% | 3.00% | +11.50 | CLSK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.1x | 31.0x | -23.90 | CLSK | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | -7.25% | -10.75 | MS | /fcf-yield <GO> |
| Operating Margin | 41.60% | 24.60% | +17.00 | CLSK | /operating-margins <GO> |
| Net Profit Margin | 47.60% | 20.20% | +27.40 | CLSK | /net-margins <GO> |
| Revenue Growth (YoY) | 102.20% | 5.50% | +96.70 | CLSK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.21% | -2.21 | MS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.46 | 0.46 | +1.00 | CLSK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | CLSK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.00% | -0.30 | CLSK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.1 | 43.3 | -14.17 | MS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.04 | -0.11 | MS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.9x | 16.5x | -11.60 | CLSK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.11B | $298.41B | -$296.30B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLSK REV | MS REV | CLSK GROSS % | MS GROSS % | CLSK FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $766.3M | $0 | 55.2% | — | -$495.5M | -$17.89B |
| FY 2024 | $379.0M | $0 | 56.3% | — | -$250.7M | $1.36B |
| FY 2023 | $168.4M | $0 | 44.0% | — | -$24.8M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLSK // BETA 0.93
MS // BETA 1.04